Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ).
TOT BIOPHARM International Co. Ltd. has announced a new composition for its board of directors and committees, effective from March 12, 2025. The board will include a mix of executive, non-executive, and independent non-executive directors, with specific roles assigned across four key committees: Audit and Connected Transactions Review, Remuneration, Nomination, and Strategy and ESG. This restructuring is likely aimed at strengthening governance and strategic oversight, potentially impacting the company’s operational focus and stakeholder engagement.
More about TOT BIOPHARM International Co. Ltd.
YTD Price Performance: 17.32%
Average Trading Volume: 107,991
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.62B
For detailed information about 1875 stock, go to TipRanks’ Stock Analysis page.